Literature DB >> 19303987

Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement.

Kai Bachmann1, Doreen Burkhardt, Inken Schreiter, Jussuf Kaifi, Paulus Schurr, Christoph Busch, Gunther Thayssen, Jakob R Izbicki, Tim Strate.   

Abstract

BACKGROUND: Myasthenia gravis (MG) is an autoimmune disease with a tremendous impact on the quality of life. Controversies over which patients should be operated on because they may benefit most from thymectomy are still ongoing. The aim of this study was to report our long-term results of patients with MG with comparison of thymectomy and conservative treatment.
METHODS: We report a series of 252 patients with MG. Survival data were generated. Patients were seen in the outpatient clinic, where a modified Osserman score and quality of life score were evaluated at the end of the follow-up period for all surviving patients.
RESULTS: A total of 172 patients with MG were followed after thymectomy or with conservative treatment for a median time of 9.8 years. Patients who underwent thymectomy had significantly greater rates of remission and improvement compared with conservative treatment. Furthermore, they had a significantly greater survival.
CONCLUSION: Currently, different effective modalities of treatment are available in patients with MG. In our long-term follow-up, thymectomy was superior to conservative treatment regarding overall survival, clinical improvement, and remission rate. Therefore, thymectomy should be considered strongly for all patients with generalized MG.

Entities:  

Mesh:

Year:  2009        PMID: 19303987     DOI: 10.1016/j.surg.2008.11.009

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  Quality of life and life circumstances in German myasthenia gravis patients.

Authors:  Sabine Twork; Susanne Wiesmeth; Jörg Klewer; Dieter Pöhlau; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-11-11       Impact factor: 3.186

2.  Thymectomy for myasthenia gravis: what's next?

Authors:  Marc de Perrot; Laura Donahoe
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

3.  Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis.

Authors:  Jinwei Zhang; Yuan Chen; Hui Zhang; Zhaoyu Yang; Peng Zhang
Journal:  Orphanet J Rare Dis       Date:  2021-05-20       Impact factor: 4.123

4.  Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants.

Authors:  Wen-Hua Xu; Ai-Mei Zhang; Ming-Shan Ren; Xu-Dong Zhang; Fang Wang; Xiu-Cai Xu; Qing Li; Jian Wang; Bang-Sheng Din; Yuan-Bo Wu; Gui-Hai Chen
Journal:  J Clin Immunol       Date:  2012-03-31       Impact factor: 8.317

Review 5.  Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review.

Authors:  Yan Luo; Deng-Ji Pan; Fei-Fei Chen; Ming-Hui Zhu; Jing Wang; Min Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

6.  Anaesthetic management of a patient with myasthenia gravis for abdominal surgery using sugammadex.

Authors:  Alina Rudzka-Nowak; Mariusz Piechota
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

7.  Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study.

Authors:  Carolina Barnett; Hans D Katzberg; Shaf Keshavjee; Vera Bril
Journal:  Orphanet J Rare Dis       Date:  2014-12-24       Impact factor: 4.123

8.  Predictive factors of prolonged mechanical ventilation, overall survival, and quality of life in patients with post-thymectomy myasthenic crisis.

Authors:  Kun-Kun Li; Kai Qian; Yong-Geng Feng; Wei Guo; Qun-You Tan; Bo Deng
Journal:  World J Surg Oncol       Date:  2017-08-08       Impact factor: 2.754

9.  Thymectomy in nonthymomatous myasthenia gravis - systematic review and meta-analysis.

Authors:  Antônio J M Cataneo; Gilmar Felisberto; Daniele C Cataneo
Journal:  Orphanet J Rare Dis       Date:  2018-06-25       Impact factor: 4.123

10.  Thymectomy: role in the treatment of myasthenia gravis.

Authors:  J Spillane; M Hayward; N P Hirsch; C Taylor; D M Kullmann; R S Howard
Journal:  J Neurol       Date:  2013-03-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.